Your browser is no longer supported. Please, upgrade your browser.
Settings
MASI Masimo Corporation daily Stock Chart
MASI [NASD]
Masimo Corporation
Index- P/E45.04 EPS (ttm)3.39 Insider Own0.60% Shs Outstand53.64M Perf Week-1.88%
Market Cap8.19B Forward P/E42.38 EPS next Y3.60 Insider Trans-48.03% Shs Float49.39M Perf Month6.81%
Income191.10M PEG3.78 EPS next Q0.87 Inst Own84.00% Short Float1.64% Perf Quarter2.77%
Sales913.50M P/S8.97 EPS this Y-4.40% Inst Trans-1.11% Short Ratio2.87 Perf Half Y5.80%
Book/sh20.70 P/B7.38 EPS next Y13.41% ROA15.60% Target Price172.40 Perf Year41.18%
Cash/sh11.81 P/C12.93 EPS next 5Y11.90% ROE18.50% 52W Range98.23 - 160.25 Perf YTD42.21%
Dividend- P/FCF53.29 EPS past 5Y27.90% ROI19.50% 52W High-4.16% Beta1.14
Dividend %- Quick Ratio5.50 Sales past 5Y9.40% Gross Margin66.80% 52W Low56.34% ATR2.72
Employees1500 Current Ratio6.20 Sales Q/Q8.70% Oper. Margin23.40% RSI (14)55.27 Volatility1.38% 1.67%
OptionableYes Debt/Eq0.00 EPS Q/Q-15.60% Profit Margin20.80% Rel Volume0.84 Prev Close152.69
ShortableYes LT Debt/Eq0.00 EarningsOct 30 AMC Payout0.00% Avg Volume282.27K Price153.58
Recom2.10 SMA200.38% SMA503.64% SMA2006.51% Volume159,805 Change0.58%
May-07-19Reiterated Needham Buy $155 → $158
Apr-16-19Downgrade BTIG Research Buy → Neutral
Mar-13-19Reiterated Needham Buy $148 → $155
Dec-19-18Upgrade Piper Jaffray Neutral → Overweight
Sep-14-18Initiated Needham Buy $139
Mar-09-18Initiated Barclays Overweight $97
Aug-14-17Upgrade BTIG Research Neutral → Buy $100
Apr-04-17Reiterated Wedbush Outperform $95 → $100
Mar-16-17Downgrade Piper Jaffray Overweight → Neutral
Feb-27-17Reiterated Wedbush Outperform $85 → $95
Feb-13-17Downgrade Raymond James Outperform → Mkt Perform
Aug-04-16Reiterated Wedbush Outperform $60 → $63
May-05-16Upgrade Piper Jaffray Neutral → Overweight
May-05-16Reiterated Wedbush Outperform $51 → $57
Jan-06-16Downgrade Raymond James Strong Buy → Outperform
Aug-05-15Reiterated ROTH Capital Buy $39 → $46
Jun-22-15Reiterated Wedbush Outperform $40 → $44
Jun-12-15Upgrade Raymond James Mkt Perform → Strong Buy $46
May-07-15Reiterated ROTH Capital Buy $29 → $38
Oct-31-13Reiterated Feltl & Co. Hold $22 → $26
Dec-09-19 08:00AM  Multicenter Study Evaluates Trend Accuracy of Noninvasive, Continuous Masimo SpHb® and Two Invasive Hemoglobin Testing Methods Business Wire
Dec-05-19 07:16PM  Do Hedge Funds Love Masimo Corporation (MASI)? Insider Monkey
Dec-02-19 09:00AM  Masimo to Present at Evercore ISI 2nd Annual HealthCONx Conference Business Wire
Nov-27-19 09:00AM  Masimo to Present at Piper Jaffray 31st Annual Healthcare Conference TEST Business Wire Releases
Nov-21-19 08:21AM  Digital Health Gaining Momentum: 3 MedTech Stocks in Focus Zacks
08:08AM  Here's Why You Should Hold on to Masimo (MASI) Stock Now Zacks
02:00AM  Study Uses Masimo Patient SafetyNet and rainbow Acoustic Monitoring® to Investigate the Incidence of Desaturation and Bradypnea in Postoperative Patients Business Wire
Nov-18-19 12:18PM  Should You Be Impressed By Masimo Corporation's (NASDAQ:MASI) ROE? Simply Wall St.
Nov-13-19 09:00AM  Masimo to Present at Stifel 2019 Healthcare Conference Business Wire
Nov-10-19 08:45PM  Edited Transcript of MASI earnings conference call or presentation 30-Oct-19 8:30pm GMT Thomson Reuters StreetEvents
Oct-31-19 07:35AM  Masimo (MASI) Earnings Beat Estimates in Q3, View Raised Zacks
04:00AM  Masimo Announces CE Marking of Radius Capnography for the Root® Patient Monitoring and Connectivity Platform Business Wire
Oct-30-19 07:15PM  Masimo (MASI) Surpasses Q3 Earnings and Revenue Estimates Zacks
04:05PM  Masimo Reports Third Quarter 2019 Financial Results Business Wire
Oct-29-19 09:59AM  Medical Products' Oct 30 Earnings Roster: MCK, MASI & More Zacks
Oct-23-19 05:00PM  Study Investigates Effects of Masimo SpHb®, Noninvasive and Continuous Hemoglobin Monitoring, on Postoperative Anemia and Inappropriate Blood Transfusion in Patients Undergoing Hip and Knee Surgery Business Wire
10:34AM  Masimo (MASI) Reports Next Week: What You Should Expect Zacks
09:55AM  Masimo Corporation (NASDAQ:MASI) Is Employing Capital Very Effectively Simply Wall St.
Oct-21-19 09:15AM  Were Hedge Funds Right About Souring On Masimo Corporation (MASI)? Insider Monkey
Oct-16-19 09:00AM  Masimo to Report Third Quarter 2019 Financial Results after Market Close on Wednesday, October 30 Business Wire
Oct-01-19 03:50PM  5 Health Care Stocks Held By Gurus GuruFocus.com
Sep-30-19 09:02AM  Here's Why You Should Retain HMS Holdings (HMSY) Stock For Now Zacks
Sep-27-19 09:11AM  Have Insiders Been Selling Masimo Corporation (NASDAQ:MASI) Shares? Simply Wall St.
Sep-25-19 11:26AM  Cerner (CERN) Set to Improve Patient Experience With New Deal Zacks
09:37AM  Here's Why You Should Hold Onto Cerner (CERN) Stock for Now Zacks
Sep-24-19 09:52AM  NextGen's (NXGN) Population Health Picked by Ohio-Based UH Zacks
Sep-23-19 02:00AM  Study Investigates the Ability of Masimo Noninvasive, Continuous Hemoglobin (SpHb®) to Provide Earlier Indication of Anemia and the Impact of Anemia on Patient Outcomes Business Wire
Sep-20-19 10:57AM  Fresenius Medical Launches 4008A Dialysis Machine in China Zacks
09:46AM  Sleep Apnea Market Gains Momentum: 3 Stocks in Focus Zacks
09:30AM  Is Masimo (MASI) Stock Outpacing Its Medical Peers This Year? Zacks
Sep-18-19 09:25AM  Accuray's (ARAY) CyberKnife Delivers Improved Patient Outcome Zacks
Sep-17-19 09:54AM  Varian's ProBeam Now Available in Multi-Room Configuration Zacks
Sep-16-19 06:52PM  5 Good Stocks to Consider Ahead of Fall 2019 GuruFocus.com
08:10AM  Varian's AI-Driven Ethos Solution to Boost Global Cancer Care Zacks
Sep-13-19 08:16AM  Medidata (MDSO) Collaborates With Mapi Research to Boost Rave Zacks
Sep-12-19 11:09AM  Ecolab's (ECL) Nalco Water Opens Customer Experience Center Zacks
Sep-10-19 08:03AM  Masimo (MASI) Boosts O3 Platform With Three New Indices Zacks
Sep-09-19 09:22AM  Here's Why Investors Should Retain Accuray (ARAY) Stock Now Zacks -5.26%
08:00AM  Masimo Announces Development of Delta cHb, HHb, and O2Hb Indices for O3® Business Wire
Sep-06-19 04:46PM  Two Leading Medical Stocks To Know As They Approach Buy Points Investor's Business Daily
Sep-05-19 10:16AM  Masimo (MASI) Introduces Pathway, Boosts Patient Monitoring Zacks
Sep-04-19 09:30AM  Is Masimo (MASI) Stock Outpacing Its Medical Peers This Year? Zacks
09:00AM  Masimo to Present at Morgan Stanley 17th Annual Global Healthcare Conference Business Wire
08:32AM  HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q2 Zacks
08:00AM  Masimo Announces Pathway, a Newborn Oxygenation Visualization Mode for the Root® Patient Monitoring and Connectivity Platform Business Wire
07:14AM  Shareholders Are Raving About How The Masimo (NASDAQ:MASI) Share Price Increased 594% Simply Wall St.
Sep-02-19 08:37AM  HealthEquity Acquires WageWorks, To Make Notable Investments Zacks
Aug-30-19 08:36AM  Cooper Companies (COO) Q3 Earnings Beat, Revenues Rise Y/Y Zacks
Aug-29-19 08:37AM  Varian's ProBeam Compact System Picked by University of Miami Zacks
08:03AM  DexCom (DXCM) Scales 52-Week High: What's Driving the Stock? Zacks
Aug-26-19 02:00AM  Study Investigates the Utility of Masimo ORi, Oxygen Reserve Index, to Reduce Hyperoxia in Critically Ill Patients Business Wire
Aug-19-19 09:30AM  Has Masimo (MASI) Outpaced Other Medical Stocks This Year? Zacks
Aug-16-19 07:33AM  The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission Benzinga
Aug-15-19 05:00PM  Masimo Announces Investment in Pulmonary Care Company TNI medical AG Business Wire
08:18AM  A Look At Masimo Corporation's (NASDAQ:MASI) Exceptional Fundamentals Simply Wall St.
01:15AM  Masimo Corp (MASI) EVP & CIO Yongsam Lee Sold $1.4 million of Shares GuruFocus.com
Aug-07-19 02:01PM  Market Volatility: A Time for Testing GuruFocus.com
02:00AM  Study Demonstrates Reduction in Mortality Using Masimo Noninvasive, Continuous Hemoglobin (SpHb®) and Pleth Variability Index (PVi®) Monitoring Business Wire
Aug-05-19 02:00AM  Masimo Announces CE Marking of Neonatal Indication for Noninvasive, Continuous Hemoglobin Monitoring (SpHb®) Business Wire
Aug-02-19 07:15PM  Masimo Corp (MASI) CEO and Chairman of the Board Joe E Kiani Sold $3.5 million of Shares GuruFocus.com
09:30AM  Is Masimo (MASI) Stock Outpacing Its Medical Peers This Year? Zacks
09:15AM  DexCom (DXCM) Hits 52-Week High, Can the Run Continue? Zacks
Aug-01-19 06:41PM  Edited Transcript of MASI earnings conference call or presentation 31-Jul-19 8:30pm GMT Thomson Reuters StreetEvents
08:24AM  Masimo (MASI) Earnings and Revenues Beat Estimates in Q2 Zacks
06:00AM  Masimo Again Ups Its Full-Year Guidance After Posting Solid Second-Quarter Growth Motley Fool
Jul-31-19 08:23PM  Masimo Corp (MASI) Q2 2019 Earnings Call Transcript Motley Fool
07:25PM  Masimo (MASI) Q2 Earnings and Revenues Beat Estimates Zacks
04:05PM  Masimo Reports Second Quarter 2019 Financial Results Business Wire
Jul-30-19 08:15PM  Masimo Corp (MASI) CEO and Chairman of the Board Joe E Kiani Sold $3 million of Shares GuruFocus.com
09:40AM  Medical Products' Earnings Roster for Jul 31: MCK, HOLX & More Zacks
Jul-26-19 09:12AM  Masimo (MASI) to Report Q2 Earnings: What's in the Offing? Zacks
Jul-24-19 10:32AM  Masimo (MASI) Q2 Earnings Preview: What's in the Cards? Zacks
Jul-23-19 07:24AM  Is Now The Time To Look At Buying Masimo Corporation (NASDAQ:MASI)? Simply Wall St.
Jul-22-19 12:30PM  The 'Short and Shoddy' Method GuruFocus.com
02:00AM  Study Investigates the Ability of Continuous Noninvasive Hemoglobin Monitoring with Masimo SpHb® to Reflect Acute Hemodilution During Incremental Fluid Administration Business Wire
Jul-17-19 09:00AM  Masimo to Report Second Quarter 2019 Financial Results after Market Close on Wednesday, July 31 Business Wire
Jul-16-19 07:59AM  Masimo (MASI) Hits a 52-Week High on Solid Growth Drivers Zacks
Jul-15-19 07:15PM  Masimo Corp (MASI) EVP & CIO Yongsam Lee Sold $1.9 million of Shares GuruFocus.com
02:00AM  New Study Investigates the Utility of Masimo ORi, Oxygen Reserve Index, As an Indicator to Avoid Hyperoxia During General Anesthesia Business Wire
Jul-12-19 08:00PM  Company Profile for Masimo Business Wire
Jul-03-19 09:15PM  Masimo Corp (MASI) CEO and Chairman of the Board Joe E Kiani Sold $15 million of Shares GuruFocus.com
03:07PM  Did You Miss Apple's 9,900% Run? How To Get Rich By Avoiding These Mental Mistakes Investor's Business Daily
11:44AM  Here's How P/E Ratios Can Help Us Understand Masimo Corporation (NASDAQ:MASI) Simply Wall St.
Jun-28-19 12:05PM  4 Lower-Risk Healthcare Picks for Long-Term Investors Motley Fool
Jun-26-19 08:06AM  Here's Why You Should Add Bruker (BRKR) to Your Portfolio Zacks
Jun-24-19 08:21AM  Here's Why You Should Buy Masimo (MASI) Stock Right Now Zacks
08:00AM  New Study Uses Masimo SedLine® Brain Function Monitoring to Assess the Prevalence of Isoelectric EEG Events in Infants and Young Children Undergoing General Anesthesia Business Wire
Jun-21-19 09:37AM  Near-Term Outlook for Medical Instruments Industry Bleak Zacks
Jun-20-19 09:02AM  DaVita Divests DMG to Optum, Boosts Kidney Care Services Zacks
07:40AM  Here's Why You Should Hold PerkinElmer (PKI) Stock for Now Zacks
Jun-18-19 08:05AM  Merit Medical Acquires Brightwater Medical for $35 Million Zacks
Jun-17-19 07:26AM  Here's Why You Should Hold Baxter International (BAX) for Now Zacks
Jun-12-19 09:27AM  Baxter's (BAX) New Sharesource 2.0 to Improve PD Treatment Zacks
09:03AM  Masimo's O3 Oximetry Gets FDA Nod, Boosts Patient Monitoring Zacks
Jun-11-19 09:21AM  Varian Medical Buys Endocare & Alicon to Boost Cancer Care Zacks
Jun-10-19 12:02PM  Should You Be Adding Masimo (NASDAQ:MASI) To Your Watchlist Today? Simply Wall St.
08:00AM  Masimo Announces FDA Clearance of Neonatal Indication for O3® Regional Oximetry Business Wire
Jun-07-19 04:26PM  Hedge Funds Have Never Been This Bullish On Masimo Corporation (MASI) Insider Monkey
Jun-06-19 09:22AM  HealthEquity (HQY) Earnings & Revenues Top Estimates in Q1 Zacks
Jun-05-19 09:30AM  Why Is Masimo (MASI) Down 2.9% Since Last Earnings Report? Zacks
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. Additionally, the company offers Trace, a patient data visualization and reporting software that monitors Masimo Root and Radical-7. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, long term care facilities, veterinarians and consumers. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FITCH SANFORDDirectorDec 06Option Exercise41.807,000292,60051,245Dec 09 06:21 PM
FITCH SANFORDDirectorDec 06Sale156.277,0001,093,91344,245Dec 09 06:21 PM
Lee YongsamEVP & CIONov 20Option Exercise28.0310,675299,22083,675Nov 21 04:09 PM
Sampath AnandEVP, Ops & Clinical ResearchNov 20Option Exercise31.0115,000465,15027,518Nov 21 04:12 PM
Lee YongsamEVP & CIONov 20Sale155.0310,6751,654,97973,000Nov 21 04:09 PM
Sampath AnandEVP, Ops & Clinical ResearchNov 20Sale155.0015,0002,325,00212,518Nov 21 04:12 PM
Lee YongsamEVP & CIONov 19Option Exercise28.031,82551,15574,825Nov 21 04:09 PM
Lee YongsamEVP & CIONov 19Sale153.161,825279,51873,000Nov 21 04:09 PM
Muhsin BilalChief Operating OfficerNov 18Option Exercise21.693,00065,0703,000Nov 19 04:10 PM
Muhsin BilalChief Operating OfficerNov 18Sale150.003,000450,0000Nov 19 04:10 PM
FITCH SANFORDDirectorNov 04Option Exercise41.806,500271,70050,745Nov 05 04:38 PM
FITCH SANFORDDirectorNov 04Sale147.086,500956,02344,245Nov 05 04:38 PM
FITCH SANFORDDirectorOct 01Option Exercise41.806,500271,70050,745Oct 02 04:55 PM
FITCH SANFORDDirectorOct 01Sale149.436,500971,26644,245Oct 02 04:55 PM
Young Micah WEVP & Chief Financial OfficerSep 16Option Exercise85.3112,0871,031,16510,000Sep 18 04:55 PM
Young Micah WEVP & Chief Financial OfficerSep 16Sale150.0212,0871,813,2910Sep 18 04:55 PM
FITCH SANFORDDirectorAug 22Sale150.397,0001,052,73044,245Aug 23 04:04 PM
Lee YongsamEVP & CIOAug 19Option Exercise28.031,07830,21674,078Aug 20 04:07 PM
Lee YongsamEVP & CIOAug 19Sale152.421,078164,31273,000Aug 20 04:07 PM
Lee YongsamEVP & CIOAug 16Option Exercise28.032,45468,78675,454Aug 16 05:32 PM
Lee YongsamEVP & CIOAug 16Sale151.402,454371,54873,000Aug 16 05:32 PM
Lee YongsamEVP & CIOAug 14Option Exercise28.031303,64473,130Aug 16 05:32 PM
Lee YongsamEVP & CIOAug 14Sale151.4713019,69173,000Aug 16 05:32 PM
Lee YongsamEVP & CIOAug 13Option Exercise26.644,981132,69176,838Aug 14 05:20 PM
Lee YongsamEVP & CIOAug 13Sale153.624,981765,18973,000Aug 14 05:20 PM
Lee YongsamEVP & CIOAug 12Option Exercise21.973,85784,73876,857Aug 14 05:20 PM
Lee YongsamEVP & CIOAug 12Sale153.353,857591,45273,000Aug 14 05:20 PM
KIANI JOE ECEO and Chairman of the BoardAug 01Option Exercise30.061,31039,379140,551Aug 02 04:15 PM
KIANI JOE ECEO and Chairman of the BoardAug 01Sale160.001,310209,600139,241Aug 02 04:15 PM
KIANI JOE ECEO and Chairman of the BoardJul 31Option Exercise30.0620,597619,146159,838Aug 02 04:15 PM
KIANI JOE ECEO and Chairman of the BoardJul 31Sale160.0120,5973,295,745139,241Aug 02 04:15 PM
KIANI JOE ECEO and Chairman of the BoardJul 26Option Exercise30.0618,437554,216157,678Jul 30 06:04 PM
Barker StevenDirectorJul 26Option Exercise28.0310,000280,30076,245Jul 30 04:22 PM
Barker StevenDirectorJul 26Sale160.0010,0001,600,00066,245Jul 30 04:22 PM
KIANI JOE ECEO and Chairman of the BoardJul 26Sale160.0218,4372,950,342139,241Jul 30 06:04 PM
Lee YongsamEVP & CIOJul 15Option Exercise21.971,17225,74974,172Jul 15 05:56 PM
Lee YongsamEVP & CIOJul 15Sale153.981,172180,46173,000Jul 15 05:56 PM
Lee YongsamEVP & CIOJul 12Option Exercise21.975,989131,57878,989Jul 15 05:56 PM
Lee YongsamEVP & CIOJul 12Sale151.835,989909,33773,000Jul 15 05:56 PM
Lee YongsamEVP & CIOJul 11Option Exercise21.975,339117,29878,339Jul 15 05:56 PM
Lee YongsamEVP & CIOJul 11Sale151.335,339807,94873,000Jul 15 05:56 PM
Barker StevenDirectorJul 01Option Exercise20.1910,000201,90076,245Jul 03 06:02 PM
KIANI JOE ECEO and Chairman of the BoardJul 01Option Exercise30.06100,0003,006,000239,241Jul 03 06:05 PM
KIANI JOE ECEO and Chairman of the BoardJul 01Sale150.14100,00015,014,000139,241Jul 03 06:05 PM
Barker StevenDirectorJul 01Sale150.0010,0001,500,00066,245Jul 03 06:02 PM
Lee YongsamEVP & CIOJun 27Option Exercise21.972585,66873,258Jun 27 07:42 PM
Lee YongsamEVP & CIOJun 27Sale145.0025837,41073,000Jun 27 07:42 PM
Lee YongsamEVP & CIOJun 26Option Exercise21.971002,19773,100Jun 27 07:42 PM
Lee YongsamEVP & CIOJun 26Sale145.0110014,50173,000Jun 27 07:42 PM
Lee YongsamEVP & CIOJun 25Option Exercise21.9773616,17073,736Jun 27 07:42 PM
Lee YongsamEVP & CIOJun 25Sale145.33736106,96373,000Jun 27 07:42 PM
Lee YongsamEVP & CIOJun 24Option Exercise21.971,07023,50874,070Jun 25 05:45 PM
Lee YongsamEVP & CIOJun 24Sale145.511,070155,69673,000Jun 25 05:45 PM
Lee YongsamEVP & CIOJun 21Option Exercise21.971,30128,58374,301Jun 25 05:45 PM
Lee YongsamEVP & CIOJun 21Sale146.221,301190,23273,000Jun 25 05:45 PM
Lee YongsamEVP & CIOJun 20Option Exercise21.215,307112,55176,035Jun 20 05:35 PM
Lee YongsamEVP & CIOJun 20Sale147.135,307780,81973,000Jun 20 05:35 PM
Lee YongsamEVP & CIOJun 19Option Exercise20.191,00020,19074,000Jun 20 05:35 PM
Lee YongsamEVP & CIOJun 19Sale145.491,000145,49073,000Jun 20 05:35 PM
Lee YongsamEVP & CIOJun 18Option Exercise20.192,72855,07875,728Jun 20 05:35 PM
Lee YongsamEVP & CIOJun 18Sale145.982,728398,23373,000Jun 20 05:35 PM
Sampath AnandEVP, Ops & Clinical ResearchJun 14Option Exercise28.0330,000840,90027,518Jun 18 04:27 PM
Sampath AnandEVP, Ops & Clinical ResearchJun 14Sale142.3930,0004,271,55012,518Jun 18 04:27 PM
Muhsin BilalChief Operating OfficerJun 10Option Exercise34.5110,000345,10010,000Jun 10 05:14 PM
Muhsin BilalChief Operating OfficerJun 10Sale140.0010,0001,400,0000Jun 10 05:14 PM
Muhsin BilalChief Operating OfficerJun 05Option Exercise21.6910,000216,90010,000Jun 07 05:07 PM
Muhsin BilalChief Operating OfficerJun 05Sale135.0010,0001,350,0000Jun 07 05:07 PM
Mikkelson AdamDirectorMay 30Option Exercise137.951,413194,9232,996Jun 03 04:19 PM
Harkin ThomasDirectorMay 30Option Exercise137.951,413194,9236,381Jun 03 04:17 PM
FITCH SANFORDDirectorMay 30Option Exercise137.951,413194,92351,245Jun 03 04:14 PM
Barker StevenDirectorMay 30Option Exercise137.951,413194,92366,245Jun 03 04:10 PM
REYNOLDS CRAIG BDirectorMay 30Option Exercise137.951,413194,9232,996Jun 03 09:42 PM
Barker StevenDirectorMay 16Option Exercise21.9710,000219,70074,832May 17 04:23 PM
Van Ramshorst David JChief Accounting OfficerMay 16Option Exercise31.401,85058,0942,500May 17 04:26 PM
Van Ramshorst David JChief Accounting OfficerMay 16Sale145.001,850268,2501,000May 17 04:26 PM
Barker StevenDirectorMay 16Sale145.0010,0001,450,00064,832May 17 04:23 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsApr 01Option Exercise31.012,00062,02013,201Apr 02 04:35 PM
Barker StevenDirectorApr 01Option Exercise20.1910,000201,90074,832Apr 02 04:36 PM
Van Ramshorst David JChief Accounting OfficerApr 01Option Exercise56.341,845103,9462,150Apr 02 04:37 PM
Van Ramshorst David JChief Accounting OfficerApr 01Sale140.001,845258,3001,000Apr 02 04:37 PM
Barker StevenDirectorApr 01Sale140.0010,0001,400,00064,832Apr 02 04:36 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsApr 01Sale140.002,000280,00011,201Apr 02 04:35 PM
Barker StevenDirectorMar 28Option Exercise21.9710,000219,70074,832Mar 29 05:04 PM
Barker StevenDirectorMar 28Sale135.0010,0001,350,00064,832Mar 29 05:04 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsFeb 27Option Exercise31.012,00062,02013,201Feb 27 04:56 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsFeb 27Sale135.002,000270,00011,201Feb 27 04:56 PM
Barker StevenDirectorFeb 25Option Exercise30.065,877176,66370,709Feb 27 04:07 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsFeb 25Option Exercise31.012,00062,02013,201Feb 27 04:56 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsFeb 25Sale130.002,000260,00011,201Feb 27 04:56 PM
Barker StevenDirectorFeb 25Sale130.005,877764,01064,832Feb 27 04:07 PM
Barker StevenDirectorFeb 19Option Exercise30.064,123123,93768,955Feb 21 05:09 PM
Barker StevenDirectorFeb 19Sale130.004,123535,99064,832Feb 21 05:09 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsJan 31Option Exercise21.972,00043,94013,201Feb 01 04:03 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsJan 31Sale125.002,000250,00011,201Feb 01 04:03 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsJan 18Option Exercise21.972,00043,94013,201Jan 22 04:09 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsJan 18Sale120.002,000240,00011,201Jan 22 04:09 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsJan 15Option Exercise21.972,00043,94013,201Jan 16 04:08 PM
Sampath AnandChief Operating OfficerJan 15Option Exercise21.9730,000659,10042,518Jan 16 04:10 PM
Sampath AnandChief Operating OfficerJan 15Sale115.0030,0003,450,00012,518Jan 16 04:10 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsJan 15Sale115.002,000230,00011,201Jan 16 04:08 PM